These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 10913401

  • 1. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae.
    Leppert D, Leib SL, Grygar C, Miller KM, Schaad UB, Holländer GA.
    Clin Infect Dis; 2000 Jul; 31(1):80-4. PubMed ID: 10913401
    [Abstract] [Full Text] [Related]

  • 2. Gelatinase B [matrix metalloproteinase (MMP)-9] and collagenases (MMP-8/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in children.
    Lindberg RL, Sorsa T, Tervahartiala T, Hoffmann F, Mellanen L, Kappos L, Schaad UB, Leib SL, Leppert D.
    Neuropathol Appl Neurobiol; 2006 Jun; 32(3):304-17. PubMed ID: 16640649
    [Abstract] [Full Text] [Related]

  • 3. Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis.
    Matsuura E, Umehara F, Hashiguchi T, Fujimoto N, Okada Y, Osame M.
    J Neurol Sci; 2000 Feb 01; 173(1):45-52. PubMed ID: 10675579
    [Abstract] [Full Text] [Related]

  • 4. Dynamic changes of matrix metalloproteinase-9 in patients with Klebsiella pneumoniae meningitis.
    Tsai HC, Liu SF, Wu KS, Liu YC, Shi MH, Chen ER, Yen CM, Lee SS, Huang YL, Chen YS.
    Inflammation; 2008 Aug 01; 31(4):247-53. PubMed ID: 18553165
    [Abstract] [Full Text] [Related]

  • 5. Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
    Liuzzi GM, Mastroianni CM, Santacroce MP, Fanelli M, D'Agostino C, Vullo V, Riccio P.
    J Neurovirol; 2000 Apr 01; 6(2):156-63. PubMed ID: 10822329
    [Abstract] [Full Text] [Related]

  • 6. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid.
    Kolb SA, Lahrtz F, Paul R, Leppert D, Nadal D, Pfister HW, Fontana A.
    J Neuroimmunol; 1998 Apr 15; 84(2):143-50. PubMed ID: 9628456
    [Abstract] [Full Text] [Related]

  • 7. Predictive value of cerebrospinal fluid matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 concentrations in childhood bacterial meningitis.
    Roine I, Pelkonen T, Bernardino L, Lauhio A, Tervahartiala T, Lappalainen M, Kataja M, Pitkäranta A, Sorsa T, Peltola H.
    Pediatr Infect Dis J; 2014 Jul 15; 33(7):675-9. PubMed ID: 24445831
    [Abstract] [Full Text] [Related]

  • 8. Effects of purulent meningitis on the changes of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase inhibitor-1 (TIMP-1) in cerebrospinal fluid of neonates.
    Cui W, Luo X, Zhang Y.
    Pak J Pharm Sci; 2019 Sep 15; 32(5(Special)):2437-2441. PubMed ID: 31894031
    [Abstract] [Full Text] [Related]

  • 9. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Niebroj-Dobosz I, Janik P, Sokołowska B, Kwiecinski H.
    Eur J Neurol; 2010 Feb 15; 17(2):226-31. PubMed ID: 19796283
    [Abstract] [Full Text] [Related]

  • 10. Changes in MMP-9 and TIMP-1 Concentrations in Cerebrospinal Fluid after 1 Week of Treatment of Childhood Bacterial Meningitis.
    Roine I, Pelkonen T, Lauhio A, Lappalainen M, Cruzeiro ML, Bernardino L, Tervahartiala T, Sorsa T, Peltola H.
    J Clin Microbiol; 2015 Jul 15; 53(7):2340-2. PubMed ID: 25903567
    [Abstract] [Full Text] [Related]

  • 11. The causative pathogen determines the inflammatory profile in cerebrospinal fluid and outcome in patients with bacterial meningitis.
    Grandgirard D, Gäumann R, Coulibaly B, Dangy JP, Sie A, Junghanss T, Schudel H, Pluschke G, Leib SL.
    Mediators Inflamm; 2013 Jul 15; 2013():312476. PubMed ID: 23864766
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The Potential Role of Matrix Metalloproteinases 8 and 9 and Myeloperoxidase in Predicting Outcomes of Bacterial Meningitis of Childhood.
    Savonius O, Roine I, Alassiri S, Tervahartiala T, Helve O, Fernández J, Peltola H, Sorsa T, Pelkonen T.
    Mediators Inflamm; 2019 Jul 15; 2019():7436932. PubMed ID: 31780869
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The cerebrospinal fluid in bacterial meningitis].
    de Campos CE, Santos NN, Takahashi MN, Kawamura IE, Damião SV, Kushnaroff TM, de Campos EP.
    Rev Soc Bras Med Trop; 1994 Jul 15; 27(2):87-91. PubMed ID: 8073157
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expression of matrix metalloproteinases, sICAM-1 and IL-8 in CSF from children with meningitis.
    Shapiro S, Miller A, Lahat N, Sobel E, Lerner A.
    J Neurol Sci; 2003 Jan 15; 206(1):43-8. PubMed ID: 12480084
    [Abstract] [Full Text] [Related]

  • 19. Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis.
    Leib SL, Leppert D, Clements J, Täuber MG.
    Infect Immun; 2000 Feb 15; 68(2):615-20. PubMed ID: 10639424
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical analysis of MMP-9, MMP-2 and TIMP-1, TIMP-2 expression in the central nervous system following infection with viral and bacterial meningitis.
    Sulik A, Chyczewski L.
    Folia Histochem Cytobiol; 2008 Feb 15; 46(4):437-42. PubMed ID: 19141395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.